CS logo
small CS logo
Klang Hospital

Bangkok, Thailand
Hospital in Bangkok
514 Luang Rd, Pom Prap, Pom Prap Sattru Phai, Bangkok 10100
500 Beds

About Klang Hospital


Bangkok Metropolitan Administration General Hospital, popularly known as Klang Hospital is a public tertiary hospital in Thailand located on corner of the Luang and Suea Pa Roads, Pom Prap Subdistrict, Pom Prap Sattru Phai District, Bangkok.
There are 500 beds in Klang Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Shenyang Sunshine Pharmaceutical Co., LTD.
2
The HIV Netherlands Australia Thailand Research Collaboration
2
Total Rows: 2

Clinical Trials at Klang Hospital


During the past decade, Klang Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22000000220000000000Started TrialsCompleted Trails201520162017201820190123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)
2015-08-01
2019-08-01
Terminated
16
Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)
2015-12-01
2021-10-09
Completed
207
Efficacy, Safety and Pharmacokinetics of DTG With RIF
2019-06-25
2024-06-30
Recruiting
200
Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals
2019-08-15
2023-03-01
Recruiting
2,500

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Klang Hospital" #1 collaborator was "Bhumibol Adulyadej Hospital" with 2 trials as a collaborator, "Klang Hospital" with 2 trials as a collaborator, "Navitas Life Sciences GmbH" with 2 trials as a collaborator, "Bamrasnaradura Infectious Diseases Institute" with 1 trials as a collaborator and "Buddhachinnaraj Hospital" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.
Created with Highcharts 11.1.0Top Leading SponsorsShenyang SunshinePharmaceutical Co.,LTD.: 2Shenyang SunshinePharmaceutical Co.,LTD.: 2The HIV NetherlandsAustralia ThailandResearch Collaboration:2The HIV NetherlandsAustralia ThailandResearch Collaboration:2

Created with Highcharts 11.1.0Top CollaboratorsBhumibol Adulyadej Hospital: 2Bhumibol Adulyadej Hospital: 2Klang Hospital: 2Klang Hospital: 2Navitas Life Sciences GmbH: 2Navitas Life Sciences GmbH: 2BamrasnaraduraInfectious DiseasesInstitute: 1BamrasnaraduraInfectious DiseasesInstitute: 1Buddhachinnaraj Hospital: 1Buddhachinnaraj Hospital: 1Chest Division,ChulalongkornUniversity: 1Chest Division,ChulalongkornUniversity: 1Chiang RaiPrachanukroh Hospital:1Chiang RaiPrachanukroh Hospital:1Department of DiseaseControl, Ministry ofPublic Health (MOPH),Thailand: 1Department of DiseaseControl, Ministry ofPublic Health (MOPH),Thailand: 1Hatyai Hospital: 1Hatyai Hospital: 1Infectious DiseaseBuddhachinarajPhitsanulok Hospital: 1Infectious DiseaseBuddhachinarajPhitsanulok Hospital: 1

Clinical Trials Conditions at Klang Hospital


According to Clinical.Site data, the most researched conditions in "Klang Hospital" are "HIV-infected Participants With Latent TB Infection in High TB Burden Country" (1 trials), "HIV/TB Coinfection" (1 trials), "Renal Anaemia" (1 trials) and "Renal Anemia" (1 trials). Many other conditions were trialed in "Klang Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Klang Hospital


Most popular intervention types in "Klang Hospital" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "EPIAO®" (2 trials), "EPREX®" (2 trials), "DTG 50 mg BID" (1 trials), "DTG 50 mg OD with food" (1 trials) and "Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klang Hospital


The vast majority of trials in "Klang Hospital" are 4 trials for "All" genders.

Clinical Trials Status at Klang Hospital


Currently, there are NaN active trials in "Klang Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klang Hospital, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klang Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 2Recruiting: 2Completed: 1Completed: 1Terminated: 1Terminated: 1